
The new changes in Genmab's salary policy, which were passed during the company's annual general meeting on Tuesday afternoon, were met with a few protests.
The Danish statutory pension fund ATP, which holds multiple shares in the company, was against these amendments.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app